Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $20.18 and last traded at $20.18, with a volume of 130 shares traded. The stock had previously closed at $20.5920.
Hikma Pharmaceuticals Trading Down 2.0%
The business has a 50 day moving average of $22.77 and a 200-day moving average of $25.30. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.72 and a current ratio of 1.24.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- What Are Trending Stocks? Trending Stocks Explained
- Why GRAIL Stock Could Be Biotech’s Next Big Breakout
- 3 Best Fintech Stocks for a Portfolio Boost
- Why Ford’s Deal With Amazon Is Bigger Than You Think
- What is diluted earnings per share (Diluted EPS)?
- Buyer Beware: Carvana Is Driving an Auto Lending Crisis
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
